321 related articles for article (PubMed ID: 21608354)
1. Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?
Reddy SV; Bhatia E
Natl Med J India; 2011; 24(1):21-7. PubMed ID: 21608354
[TBL] [Abstract][Full Text] [Related]
2. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
3. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
Nichols GA; Joshua-Gotlib S; Parasuraman S
J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
; Wing RR
Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study.
Shinohara K; Ikeda S; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
Hypertens Res; 2021 Dec; 44(12):1606-1616. PubMed ID: 34526672
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes.
Kunutsor SK; Balasubramanian VG; Zaccardi F; Gillies CL; Aroda VR; Seidu S; Khunti K
Diabetes Obes Metab; 2024 Jun; 26(6):2069-2081. PubMed ID: 38409644
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and cardiovascular disease: what next?
Joseph JJ; Golden SH
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):109-20. PubMed ID: 24569552
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
[TBL] [Abstract][Full Text] [Related]
9. Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks.
Bergenstal RM; Li Y; Porter TK; Weaver C; Han J
Diabetes Obes Metab; 2013 Mar; 15(3):264-71. PubMed ID: 23078638
[TBL] [Abstract][Full Text] [Related]
10. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
BMJ; 2011 Nov; 343():d6898. PubMed ID: 22115901
[TBL] [Abstract][Full Text] [Related]
11. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
12. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
[TBL] [Abstract][Full Text] [Related]
14. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
Zhang DA; Katznelson L; Li M
J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
[TBL] [Abstract][Full Text] [Related]
15. Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial.
Chiavaroli L; Mirrahimi A; Ireland C; Mitchell S; Sahye-Pudaruth S; Coveney J; Olowoyeye O; Maraj T; Patel D; de Souza RJ; Augustin LS; Bashyam B; Blanco Mejia S; Nishi SK; Leiter LA; Josse RG; McKeown-Eyssen G; Moody AR; Berger AR; Kendall CW; Sievenpiper JL; Jenkins DJ
BMJ Open; 2016 Jul; 6(7):e012220. PubMed ID: 27388364
[TBL] [Abstract][Full Text] [Related]
16. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
17. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
[TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
19. Intensive glycemic control and cardiovascular disease: are there patients who may benefit?
Chokrungvaranon N; Deer J; Reaven PD
Postgrad Med; 2011 Nov; 123(6):114-23. PubMed ID: 22104460
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
